Spur Therapeutics

Developer of gene therapies for debilitating chronic diseases

placeStevenage, England, United Kingdom calendar_todayFounded 2015 language spurtherapeutics.com

Innovation

4 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 234 times.

YearFilings
20211
20221
20231
20253
20261

Investor mix

10 investors on record; lead investors include Syncona, Novo Holdings, Eventide Asset Management, Wellington.

Investor typeCountShare
Venture capital440%
Private equity220%
Bank & private debt110%
Other / undisclosed330%
Coming soon